Centri GCxGC-TOF-MS system

Award

Value

£317,358

Classifications

  • Detection and analysis apparatus

Tags

  • award
  • contract

Published

3 years ago

Description

For the purchase of Centri GCxGC-TOF-MS system for the discovery, profiling, and screening of volatile organic compounds. This equipment has been selected for the ability to allow automated HiSorb immersive extraction. Samples can be stacked and run in sequence, with detachment of probes from the robot arm allowing for the next sample extraction to begin. The robot then recollects the probe and inserts into the platform. The system allows for any injected samples to be recollected onto thermal desorption tubes, facilitating multiple analyses of the same extract. The mass spectrometer features tandem ionisation capability, which allows for generation of mass spectra profiles at two different ionisation energies simultaneously. This allows for increased confidence in compound identification and facilitates structural elucidation and isotope ratios. The entire platform is operated with ChromSpace software, allowing for integrated control of Centri automated extraction, GC injection, flow modulation, flame ionisation detection quantification, mass spectrometer operation, data processing, and statistical analysis.
The University has published this Award notice following the publication of the VEAT notice and expiry of 10 calendar days and has awarded a contract to Markes International Analytical Limited.

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download
  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

Open

250262 - Contract for Supply, Delivery, Installation & Commissioning of a Surface Plasmon Resonance (SPR) System.

The Future Medicines Institute (FMI) requires a Surface Plasmon Resonance (SPR) system with advanced capabilities for real-time, label-free analysis of biomolecular interactions. (Maximum budget available for Equipment inclusive of 3 years extended warranty & annual preventative maintenance is is £330,000). The primary objective of procuring an SPR device is to enhance FMI’s capacity to characterise binding kinetics, affinity, and specificity of biomolecular interactions, thereby strengthening its protein science and drug discovery workflows. The proposed system must: • Provide precise kinetic and affinity measurements for a wide range of biomolecular interactions, including protein–protein, protein–antibody, and protein–small molecule binding. • Deliver high sensitivity and reproducibility to ensure reliable and quantitative data across experiments. • Support automation and high-throughput analysis, enabling efficient screening of large sample sets. • Include robust data analysis software for comprehensive kinetic modelling and data interpretation. • Offer versatile assay configurations, supporting various experimental formats and immobilisation chemistries. • Integrate seamlessly with upstream and downstream workflows, including protein purification and structural analysis. The procurement of a high-performance SPR system directly supports FMI’s broader goals of: • Accelerating drug discovery through rapid identification and characterisation of therapeutic candidates. • Enhancing biopharmaceutical research by enabling detailed analysis of binding mechanisms critical to biologics development. • Facilitating translational research by bridging fundamental molecular interaction studies with clinical and therapeutic applications. This procurement will provide direct benefit to research scientists by: • Reducing manual intervention and experimental variability through automation and streamlined workflows. • Enhancing data quality with high-resolution detection and advanced signal processing for accurate kinetic profiling. • Please note: - The execution of this tender & contract will be solely dependent on grant funding being received, which is estimated to be confirmed in November 2025. • No award will be made, or orders issued until the grant funding has been confirmed. If grant funding is not secured, the market will be notified, and this procurement exercise will be stood down.

Katy Reed

Published 5 days ago

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline complete

Publish
Bid
Evaluate
Award
Complete